+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects



Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects



Aids 16(14): 1915-1923



Objectives: The impact of highly active antiretroviral therapy (HAART) on hepatitis C virus (HCV) is unknown. We analysed changes in HCV RNA and the frequency of hepatotoxicity in co-infected patient enrolling in AIDS Clinical Trials Group trials, and determined whether HCV impairs successful immune reconstitution in these populations. Design/methods: In a prospective analysis of co-infected patients completing at least 16 weeks of HAART in four trials, and co-infected patients with available stored plasma from two other completed HAART trials, HCV RNA was measured at baseline and to week 48. A retrospective analysis of immune recovery in 40 HCV-RNA-positive and 129 HCV-RNA-negative patients from a single trial was performed. Results: Prospective analysis: 60 patients completed at least 16 weeks of HAART. The mean HCV-RNA level increased 0.35 log10 IU/ml at week 16 and 0.43 log10 IU/ml at week 48. When stratified by baseline CD4 cell count, subjects' HCV-RNA levels increased 0.43 and 0.59 log10 IU/ml at weeks 16 and 48 for entry CD4 cell counts <350 cells/mm3, but only 0.26 and 0.1 log10 IU/ml at weeks 16 and 48 for entry CD4 cell counts >350 cells/mm3. Severe alanine aminotransferase elevations occurred in only 3.3%. Retrospective analysis: HCV co-infection had no effect on the overall mean CD4 cell increase at weeks 16 or 48 compared with uninfected controls. Conclusion: In HCV-co-infected patients undergoing HAART, immune recovery is associated with a persistent increase in HCV RNA, especially with baseline CD4 cell counts <350 cells/mm3. HCV co-infection did not antagonize the CD4 cell response to HAART.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010794057

Download citation: RISBibTeXText

PMID: 12351951

DOI: 10.1097/00002030-200209270-00008


Related references

Immune Recovery Is Associated With Persistent Rise In Hepatitis C Virus Rna, Infrequent Liver Test Flares, And Is Not Impaired By Hepatitis C Virus In Co-Infected Subjects. Infectious Diseases in Clinical Practice 11(5): 322-323, 2002

Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1. Aids 19(8): 775-784, 2005

Hepatitis C virus coinfection is a less frequent but more important cause of liver disease than hepatitis B virus in HIV-1 sexually infected subjects. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 345, 1993

Induction and maintenance of anti-HBs in immunosuppressed murine hepatitis B virus carriers by a novel vaccination approach: implications for use in hepatitis B virus-infected subjects with liver transplantation. Journal of Gastroenterology 39(9): 851-858, 2004

Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin. Journal of Viral Hepatitis 25(7): 834-841, 2018

Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft. Aids 27(16): 2655-2657, 2014

Prevalence of previous hepatitis A virus infection in renal transplant patients with hepatitis C: evidence of persistent anti-hepatitis A virus immune response. Transplantation Proceedings 36(5): 1500-1501, 2004

Histological changes in hepatitis C virus antibody-positive, hepatitis C virus RNA-negative subjects suggest persistent virus infection. Hepatology 49(4): 1392; Author Reply 1392-3, 2009

Severe hepatitis and prolonged hepatitis B virus-specific CD8 T-cell response after selection of hepatitis R virus YMDD variant in an HIV/hepatitis B virus-co-infected patient. AIDS 18(12): 1734-1737, August 20, 2004

Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection. Journal of Gastroenterology and Hepatology 24(4): 588-598, 2009

Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients. Journal Of Medical Virology. 54(4): 249-255, Il, 1998

Persistence of hepatitis b virus infection extrachromosomal monomeric hepatitis b virus dna in liver cell nuclei of a patient serologically immune to hepatitis b virus infection. Hepatology 6(5): 1141, 1986

Persisting hepatitis E virus infection leading to liver cirrhosis despite recovery of the immune system in an HIV-infected patient. Clinics and Research in Hepatology and Gastroenterology 40(3): E23-E25, 2018

Liver Function Tests Abnormalities and Hepatitis B Virus & Hepatitis C Virus Co-infection in Human Immunodeficiency Virus (HIV)-infected Patients in India. Journal of Clinical and Experimental Hepatology 7(1): 1-8, 2017

Soluble CD163 is associated with noninvasive measures of liver fibrosis in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected women. Hepatology 61(2): 734-735, 2015